Immunology is the study of the immune system, which protects the body from foreign invaders like bacteria and viruses. It involves complex cellular and molecular mechanisms that defend the host from infection or disease. Global immunology market encompasses various assays, kits, instruments and software that are used for various purposes like disease diagnosis, drug development and research activities. It caters to end users like hospitals, research institutes, pharmaceutical and biotechnology companies. The market has witnessed significant growth due to increasing prevalence of chronic diseases, rising focus on personalized medicine and growing adoption of biomarkers and companion diagnostics. However, high costs of tests and regulatory issues can pose challenges to market players. The advancements in immunoassay technologies, growing biologics industry, and popularity of poised can drive the immunology market growth in the near future.

Market Dynamics:

Global immunology market growth is driven by increasing prevalence of chronic diseases like cancer, diabetes and cardiovascular disorders. According to the data from WHO, chronic diseases accounted for over 70% of all deaths globally in 2020. Growing geriatric population can also drive the market growth as age increases the risk of above-mentioned conditions. Rising focus on precision medicine has bolstered the development and adoption of biomarkers, companion diagnostics and immunoassay tests in disease management. This is expected to boost demand for immunology products over the forecast period. However, high costs associated with advanced tests can pose significant challenges, especially in price-sensitive developing markets. Stringent regulatory processes for new product approvals can also delay market entry for players. Rising research activities especially in the fields of cancer immunology and immunotherapy can present lucrative opportunities. Continuous technological advancements in assay development can also expand the applications of immunology products.

Key Features of the Study:

• This report provides in-depth analysis of the global immunology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global immunology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corporation, Beckman Coulter Inc, Danaher Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global immunology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunology market.

Detailed Segmentation-

• By Drug Class
  
  • Monoclonal Antibody (mAb)
  • Fusion Proteins
  • Immunosuppressants
  • Polyclonal Antibody (pAb) 
  • Others
• By Disease Indication
  
  • Rheumatoid Arthritis  
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
• By Distribution Channel
  
  • Hospital Pharmacies
  • Retail Pharmacies 
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.